Hemington Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History
Hemington Wealth Management
- $691 Million
- Q2 2025
A detailed history of Hemington Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 89 shares of REGN stock, worth $49,532. This represents 0.01% of its overall portfolio holdings.
Number of Shares
89
Previous 125
28.8%
Holding current value
$49,532
Previous $79,000
41.77%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,396Shares Held
87.6MCall Options Held
1.38MPut Options Held
1.37M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.24 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.15 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.67 Billion0.13% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.13 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...